Over 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 45 senior level industry speakers from leading pharmaceutical, biotechnology organisations as well as academia covering the following hot topics:

R&D STRATEGIES –Strategies to enhance drug discovery, overcoming attrition, prediction tools that drive clear decision rules, risk management

DRUG DESIGN & TARGETS – GPCR’s, RNAi, and Protein Kinases, reducing risk of toxicity, structure based discovery, hit to lead strategies, fragment based techniques

SCREENING TECHNIQUES & ASSAY DEVELOPMENT – Improving quality of assays, cost effective HTS & HCS, moving towards more complex systems

PHARMA/BIOTECH ALLIANCES COLLABORATIONS & OUTSOURCING –,Successful partnerships, managing alliances, balancing conflicting interests, biotech technology platforms

BIOMARKERS & TRANSLATIONAL MEDICINE –Personalised medicine, decision making tools, surrogate endpoints, translational strategies, validation, biobanking

IN SILICO APPROACHES TO SOLVE DRUG DISCOVERY – In-silico data, data mining, predictive modelling, systems biology